Bioheart, Inc. (OTCQB: BHRT) is an emerging enterprise in the regenerative medicine industry focused on the discovery, development and commercialization of cell-based therapeutics that prevent, treat or cure cardiovascular diseases. The company’s leading product candidate is MyoCell®, a muscle stem cell therapy that is intended to improve cardiac function in patients with severe heart damage […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.